Skip to Content
Merck
All Photos(3)

Documents

911860

Sigma-Aldrich

NanoFabTx microfluidic - micro

device kit for synthesis of 1-5 μm particles

Synonym(s):

Microfluidic kit, Microparticle, NanoFabTx device kit, Nanoformulation

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12162002
UNSPSC Code:
41121811
NACRES:
NA.23

description

Microfludic device kit for synthesizing 1-5 μm microparticles

Kit components :

  • Microfluidic chip x 1
  • Tubings and accessories

Quality Level

application(s)

advanced drug delivery

Looking for similar products? Visit Product Comparison Guide

General description

NanoFabTx Microfluidic - micro device kit includes a comprehensive protocol, pre-assembled microfluidic chip manifold, tubing, and accessories—a microfluidic platform to synthesize drug-encapsulating microparticles 1-5 μm in size. It is compatible with either a standard syringe pump (not included) or the Dolomite microfluidics system (not included). The device kit does not include reagents. NanoFabTx- micro reagent kits, like NanoFabTx PLGA-micro (Cat.No. 912220) provide the reagents for the synthesis of 1-5 μm PLGA microparticles.

Application

NanoFabTx Microfluidic - micro device kit is designed to work with the NanoFabTx- micro reagent kits for the synthesis of 1-5 μm particles (Cat.No. 912220) and can be used to create drug-encapsulated polymeric microspheres with narrow size-dispersity and consistent drug loading. Polymeric microparticles also can encapsulate larger biologics like proteins, mRNA, and DNA, in addition to drugs and small molecules, and may serve as vehicles for targeted delivery and controlled release. Microfluidic-based synthesis is a powerful tool in drug development for fabricating size-controlled drug-delivery particles, enabling scalable synthesis of particles and rapid formulation screening. In contrast to nanoprecipitation or solvent-displacement methods, microfluidic technologies have several advantages including enhanced reproducibility, less consumption of expensive reagents, and superior scalability.

Features and Benefits

  • Step-by-step microfluidic-based protocols developed and tested by our formulation scientists
  • Optimized to make monodisperse microparticles of any size between 1 and 5 μm
  • Facilitates simple optimization of drug encapsulation and loading efficiency in microparticles

Legal Information

NANOFABTX is a trademark of Sigma-Aldrich Co. LLC

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service